U.S.: Pfizer COVID-19 Vaccine Appears Effective For Kids Under 5
Newsy
The review from the Food and Drug Administration is a key step toward an expected decision to begin vaccinating babies, toddlers and preschoolers.
A review by federal health officials says that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently A review by federal health officials finds that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination.
The review issued Sunday by the Food and Drug Administration is a key step toward a decision on vaccinations for babies, toddlers and preschoolers, perhaps as soon as June 21. Parents have been waiting months to protect America's youngest children, who number roughly 18 million.
The FDA said children who received the kid-sized shots developed a strong immune response to help fight off the coronavirus. That's the requirement needed to win FDA authorization.